Covered recipient · General Payments record
LARA V MARCUSE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,802.19
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $702.42 | 26 |
| Education | $29.68 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $278.93 | 6 |
| UCB, Inc. | $169.52 | 8 |
| Neurelis, Inc. | $142.65 | 10 |
| NEUROPACE, INC. | $75.20 | 1 |
| JAZZ PHARMACEUTICALS INC. | $49.08 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 11/05/2024 | Education | Undisputed | 01/23/2026 | 1144452497 | CMS |
| JAZZ PHARMACEUTICALS INC. | $19.37 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216574 | CMS |
| JAZZ PHARMACEUTICALS INC. | $29.71 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216576 | CMS |
| Neurelis, Inc. | $18.27 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647524 | CMS |
| Neurelis, Inc. | $1.29 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647526 | CMS |
| Neurelis, Inc. | $19.76 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647528 | CMS |
| Neurelis, Inc. | $4.16 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647530 | CMS |
| Neurelis, Inc. | $12.96 | 05/20/2024 | Education | Undisputed | 01/23/2026 | 1145647532 | CMS |
| Neurelis, Inc. | $29.87 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647534 | CMS |
| Neurelis, Inc. | $9.15 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647536 | CMS |
| Neurelis, Inc. | $26.05 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647538 | CMS |
| Neurelis, Inc. | $4.17 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647540 | CMS |
| Neurelis, Inc. | $16.97 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145647542 | CMS |
| NEUROPACE, INC. | $75.20 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153272612 | CMS |
| SK Life Science, Inc. | $111.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117472 | CMS |
| SK Life Science, Inc. | $9.71 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117480 | CMS |
| SK Life Science, Inc. | $13.61 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117478 | CMS |
| SK Life Science, Inc. | $3.91 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117488 | CMS |
| SK Life Science, Inc. | $25.94 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117486 | CMS |
| SK Life Science, Inc. | $114.34 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117572 | CMS |
| UCB, Inc. | $26.66 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300249 | CMS |
| UCB, Inc. | $32.07 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300254 | CMS |
| UCB, Inc. | $1.35 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300258 | CMS |
| UCB, Inc. | $21.25 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300263 | CMS |
| UCB, Inc. | $24.79 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300267 | CMS |
| UCB, Inc. | $22.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300271 | CMS |
| UCB, Inc. | $18.67 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300276 | CMS |
| UCB, Inc. | $22.05 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143300280 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.